Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures
Open Access
- 2 August 2014
- journal article
- research article
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 9 (1) , 134
Abstract
Topical hemostatic agents are used to reduce bleeding and transfusion need during cardiothoracic surgery. We report our experience with Arista® AH Absorbable Hemostatic Particles (Arista® AH), a novel plant-based microporous polysaccharide hemostatic powder.Keywords
This publication has 16 references indexed in Scilit:
- Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Safety and Efficacy of Microporous Polysaccharide Hemospheres in NeurosurgeryOperative Neurosurgery, 2011
- The Use of a Powdered Polysaccharide Hemostat (HemoStase) in Live Donor Nephrectomies Controls Bleeding and Reduces Postoperative ComplicationsTransplantation Proceedings, 2011
- Prospective, Randomized Clinical Trial of the FloSeal Matrix Sealant in Cardiac SurgeryThe Annals of Thoracic Surgery, 2009
- Advances in Absorbable Biomaterials and Nasal PackingOtolaryngologic Clinics of North America, 2009
- Effect of Microporous Polysaccharide Hemospheres (MPH) on Bleeding after Endoscopic Sinus SurgeryOtolaryngology–Head and Neck Surgery, 2009
- Costs of excessive postoperative hemorrhage in cardiac surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Transfusion and hemostasis in cardiac surgeryTransfusion, 2008
- Hemorrhage related reexploration following open heart surgery: the impact of pre-operative and post-operative coagulation testingCardiovascular Surgery, 2002
- Controlled clinical trial of a novel hemostatic agent in cardiac surgeryThe Annals of Thoracic Surgery, 2000